Get Healthy!

Results for search "Viruses".

23 Sep

Pregnant Women Who Get COVID Vaccine Pass Antibodies to Newborns

Expectant moms who receive mRNA Covid-19 vaccines pass antibodies to their newborns, researchers find.

Health News Results - 1174

Two-Thirds of Parents of Kids Ages 5-11 Plan to Get Them Vaccinated Against COVID: Poll

In some heartening news on the vaccine front, two-thirds of American parents of children ages 5 to 11 plan to get their youngsters vaccinated when COVID-19 shots are approved for that age group, a new survey shows.

"While we're encouraged to see that a majority of parents intend to vaccinate their children against COVID-19 once they are eligible, there is clearly more work to be done to h...

Another Study Finds Pfizer, Moderna Shots Effective Against COVID Variants

The Moderna and Pfizer COVID vaccines protect against a number of coronavirus variants, including highly contagious Delta, another study confirms.

The findings come as breakthrough infections in vaccinated people raise questions about the vaccines' ability to protect against emerging variants.

The shots do "induce high levels of antibodies against Delta and most variants," said stud...

Is a Really Bad Flu Season on the Way?

It could be a bad flu season this year — and for a couple of years to come — in places in the United States where COVID-19 restrictions like social distancing and masking have been lifted, researchers warn.

These sorts of measures caused flu cases to decline by more than 60% within the first 10 weeks after COVID-19 lockdowns were implemented in 2020, Columbia University researchers fo...

More Than Half of COVID-19 Survivors Will Get 'Long COVID'

Long-term symptoms of coronavirus infection, known as 'long COVID,' affects more than half of COVID-19 survivors, and health care systems should be prepared to treat them, researchers say.

So far, 236 million people worldwide have been diagnosed with COVID-19, and many have had lingering physical and mental health problems for six months or longer.

"The burden of poor health in COV...

Kids Can Carry High, Infectious Levels of COVID Coronavirus

THURSDAY, Oct. 14, 2021 (HealthDay News) – From newborns to new adults, young people who get COVID-19 can carry high levels of the virus and spread it to others even if they show no symptoms.

That's the takeaway from a study of 110 people between 2 weeks and 21 years of age who tested positive for SARS-CoV-2 infection.

Researchers found that infants, children and teens were equall...

FDA Questions Strength of Johnson & Johnson's Booster Shot Data

In a development that could mean Johnson & Johnson might encounter resistance over its application for authorization of a booster shot of its coronavirus vaccine, a new analysis filed by the U.S. Food and Drug Administration on Wednesday suggests the company's evidence may not be strong enough for approval.

A key test used by the company to measure immune response from a booster shot six ...

Merck Asks FDA to Approve First COVID Antiviral Pill

Merck & Co. announced Monday that it had submitted an application with the U.S. Food and Drug Administration for emergency use approval of the first antiviral pill targeted to COVID-19.

Experts say authorization of molnupiravir, at this time only for use inhigh-risk Americans, could be a major advance in the struggle against COVID-19 because a convenient, more affordable trea...

60% of Americans Will Delay or Skip Flu Shot This Year: Survey

Experts are warning that the upcoming flu season could be severe as social distancing measures are relaxed across the United States, but a new survey finds that 6 in 10 Americans may delay or skip a flu shot.

However, it also found that 98% of those who got a flu shot last season do plan to get one again this year.

While 82% of the 1,000 adult participants of the online survey sai...

Risk of COVID from Grocery Store Surfaces Very Low: Study

Your chances of getting COVID-19 from surfaces at the grocery store are minimal, a Canadian study reassures.

Researchers at the University of Guelph in Ontario collected 957 samples at four grocery stories over a month. None tested positive for SARS-CoV-2, the virus that causes COVID,

  • Cara Murez
  • |
  • October 12, 2021
  • |
  • Full Page
  • Pfizer Seeks FDA Emergency Approval for COVID Vaccine in Younger Kids

    Pfizer Inc. announced Thursday that it has asked the U.S. Food and Drug Administration for emergency approval for its coronavirus vaccine to be given to children between the ages of 5 and 11.

    "We're committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat," the company said in a

    Japanese Scientists Discover New Disease Carried by Ticks

    Scientists in Japan have discovered yet another tick-borne virus that can make people sick.

    The Yezo virus is transmitted by tick bites, and triggers fever and a reduction in blood platelets and white blood cells.

    "At least seven people have been infected with this new virus in Japan since 2014, but, so far, no deaths have been confirmed," said Keita Matsuno, a virologist at Hokkaid...

    COVID Hospitalizations Are Rising Among Unvaccinated Pregnant Women

    Since the rise of the Delta variant, one Texas hospital has seen a surge in severe COVID-19 among pregnant women — nearly all unvaccinated.

    Researchers at the Dallas hospital found that in late August and early September, 10% to 15% of pregnant patients who tested positive for COVID-19 needed to be hospitalized for severe illness.

    That was more than double the percentage of a year...

    Minorities Bore the Brunt of U.S. COVID Deaths: Study

    The ongoing coronavirus pandemic has hit minority groups in the United States hard, with significantly more deaths among Black and Hispanic Americans compared with white and Asian Americans, a new study finds.

    According to the report, these disparities highlight the need to address ongoing inequities influencing health and longevity in the United States.

    What's more, "focusing on CO...

    EU Drug Regulator OKs Pfizer COVID-19 Vaccine Booster Shots

    Booster shots of the Pfizer-BioNTech coronavirus vaccine for people aged 18 and older have been given the green light by the European Medicines Agency.

    They "may be considered at least six months after the second dose for people aged 18 years and older," the European Union's drug regulator said Monday, the Associated Press reported.

    The advice is based on data showing that ...

    Powerful New Antivirals for COVID Are Coming

    People newly infected with COVID-19 might soon have access to what essentially is Tamiflu for the novel coronavirus, a breakthrough that experts say would drastically alter the course of the ongoing pandemic.

    At least three contenders are vying to become the first antiviral pill that specifically targets COVID-19, according to reports from drug manufacturers.

    Such a pill could be pr...

    Merck to Ask FDA for Emergency Approval of Its New Antiviral Pill for COVID

    Pharmaceutical giant Merck & Co. said Friday that it will seek federal approval for emergency use of its new antiviral pill molnupiravir, after a clinical trial showed the drug halved the risk of hospitalization or death when given to high-risk people shortly after infection with COVID-19.

    The new medication is just one of several antiviral pills now being tested in studies, and experts s...

    SmartWatches Detect Viral Infection Before Symptoms Surface in Study

    Someday, your smartwatch might be able to tell you if you're coming down with a virus and how sick you'll be — even before symptoms start.

    In a small study, researchers showed that a wearable device, like a Fitbit or Apple Watch, could detect which patients had the H1N1 flu and which had a common cold.

    "One of our goals was to be able to detect that infection before a person feel...

    AI Model Predicts Which Animal Viruses Are Likely to Jump to Humans

    Artificial intelligence (AI) might be able to spot the next virus to jump from animals to humans, Scottish researchers report.

    Identifying diseases before they become a threat to humans is challenging, because only a few of the nearly 2 million animal viruses can infect humans. By developing machine learning models, researchers can analyze genetic patterns of viruses that might infect peo...

    You Think You Had COVID Before: Are You Really Immune Now?

    It seems like common sense for people who've had COVID-19 to think they now have natural immunity, and therefore don't have to bother getting vaccinated.

    Common sense, yes, but also incorrect, infectious disease doctors say.

    Your case of COVID — especially if it was very mild — probably didn't create enough of an immune response to provide lasting protection against SARS-CoV-2, ...

    DNA Sensor Can Spot When COVID Is Contagious

    A new DNA sensor can detect viruses and tell if they are infectious or not in minutes, a new study finds.

    The sensor was developed by using DNA technology, and does not require the need to pretreat test samples. Researchers demonstrated this technique with the human adenovirus (which causes colds and flu) and the virus that causes COVID-19.

    "The infectivity status is very important...

    Can Llama Antibodies Fight COVID in Humans? New Research Says They Might

    The future of COVID-19 treatments might include a tiny antibody made by llamas.

    British researchers credit a llama named Fifi with their finding.

    The investigators said these llama nanobodies, which are also produced by camels, could eventually be produced in a lab and administered by a nasal spray, binding tightly to the COVID-19 virus and neutralizing it.

    The potential solu...

    Pregnant Women Who Get COVID Vaccine Pass Antibodies to Newborns

    One way to help protect newborns from COVID-19 is for women to get their COVID vaccine while pregnant.

    A new study found that mothers-to-be who had either the Pfizer-BioNTech or Moderna vaccine passed high levels of antibodies to their infants.

    Researchers from the NYU Grossman School of Medicine discovered that 100% of 36 newborns tested at the time of birth had protective antibo...

    Antibodies to Early Strains of COVID May Not Fight New Variants: Study

    Antibodies from current COVID-19 vaccines don't bind well to the new variants of the virus, a study finds.

    Researchers collected data from previously published papers about the sequence of antibodies produced by the vaccines. They focused on antibodies against the spike protein, a part of the virus that binds to receptors on human cells to infect them. It's the target of most vaccines.

    Booster Dose of J&J COVID Vaccine Increases Immunity

    Getting another shot of the Johnson & Johnson COVID-19 vaccine substantially increased its protection, the company announced Tuesday.

    According to the results of a new clinical trial, two doses of the vaccine boosts immunity to 94% from the 74% offered by a single dose, the company said in a statement.

    "Our single-shot vaccine generates strong immune responses and long-lasting immun...

    COVID Has Killed More Americans Than the Spanish Flu Did in 1918

    As the highly contagious Delta variant has swept across the United States, the country has reached a tragic milestone.

    COVID-19 has now killed more Americans than the 1918 Spanish flu pandemic did, when roughly 675,000 people died.

    It didn't have to be that way.

    "Big pockets of American society — and worse, their leaders — have thrown this away" by not getting vaccinated, ...

    Delta Variant Now Fueling 99% of U.S. COVID Cases

    If a person is diagnosed with COVID-19 in the United States right now, it's almost certainly caused by the Delta variant.

    The highly transmissible variant, which caused crippling surges in India and Britain this past spring and fueled case spikes in the United States this summer, is now responsible for over 99% of all cases tracked in this country, according to the latest data from the

    Study Spots People at High Risk of Severe Breakthrough COVID

    A study of millions of people vaccinated against COVID-19 has identified those at greatest risk of hospitalization and death after breakthrough infection.

    The most vulnerable are those who are immunosuppressed from chemotherapy, a recent bone marrow or solid organ transplant, or HIV/AIDS. Also at risk are people with neurological disorders (such as dementia and Parkinson's disease), nur...

    FDA Panel OKs Pfizer Booster Shot for  People 65 or Older, But Not Younger

    An advisory panel to the U.S. Food and Drug Administration on Friday recommended a third Pfizer-BioNTech COVID vaccine booster shot for all Americans aged 65 or older, as well as for those deemed to be at high risk for severe illness.

    According to The New York Times, that vote came after a near unanimous decision (16 to 2) by the same independent panel of experts that sa...

    Long-Haul COVID in Kids Typically Ends Within 3 Months: Study

    In kids and teens, symptoms of long COVID rarely last more than 12 weeks, a new international study reports.

    The researchers also found that exposure to the highly contagious Delta variant did not result in more serious disease in children compared to earlier variants, and that most cases of COVID-19 were asymptomatic or mild.

    Despite those reassurances, the study did include a trou...

    FDA Advisory Panel to Meet on COVID Booster Shots

    U.S. Food and Drug Administration advisors will meet Friday to consider whether it is safe and effective for Americans to receive a third "booster" dose of the Pfizer-BioNTech COVID-19 vaccine.

    The FDA posted the materials it intends to use in the review on Wednesday. The advisory panel will review a variety of evidence, including new data from Israel, the Associated Press<...

    Is Flu Ready for a Comeback? Get Your Shot

    Health officials are bracing for a viral double whammy this fall and winter.

    "This year, we expect influenza and COVID-19 to circulate at the same time," said Dr. Jonathan Grein, director of hospital epidemiology at Cedars-Sinai in Los Angeles.

    That's why Grein and his colleagues remind Americans that it's time to get your seasonal flu shot. This fall, it's not only a key to keepin...

    Biden Administration Buys More Monoclonal Antibody Treatments to Ward Off Shortage

    As severe cases of COVID-19 rise and demand surges for monoclonal antibody treatments, the U.S. government is ordering more from two key suppliers.

    Monoclonal antibodies, which are lab-engineered immune system proteins, can help trigger a healthy immune response against COVID-19 infection.

    The Biden administration has also taken over distributing the therapeutics, to help avoid shor...

    How Effective Is Your Homemade Mask?

    If you're making your own face mask to protect against COVID-19, three layers of cotton towel fabric are best, researchers from India report.

    That recommendation comes after testing how best to block cough droplets moving at different rates, from mild to severe.

    "Our results show cotton, towel-based fabrics were most effective among the considered fabrics and must be stitched toget...

    Your Diet Could Cut Your Odds for Severe COVID-19

    People who eat plenty of fruits and vegetables may have a somewhat lower risk of COVID-19 than those with unhealthy diets, a new study suggests.

    Of more than 590,000 adults surveyed, researchers found that the quarter with the most plant-rich diets had a 9% lower risk of developing COVID-19 than the quarter with the least-healthy diets.

    Their risk of severe COVID-19, meanwhile, was ...

    Israeli Data on COVID Boosters to Be Published This Week in Major Journal

    TUESDAY, Sept. 14, 2021 (HealthDay News) -- New data out of Israel, to be published this week, could bolster the notion that a third booster shot of the COVID-19 vaccine significantly lowers a recipient's odds for severe illness.

    The data is scheduled to be published in the peer-reviewed New England Journal of Medicine, ahead of this week's U.S. Food and Drug Administra...

    Britain OK's COVID Vaccine for Kids 12 and Older; Hopes to Avoid Lockdowns

    While in the United States preteens and teens aged 12 to 15 have been eligible for COVID-19 vaccines since the spring, the vaccines are only now becoming available for that age group in the United Kingdom.

    According to the Associated Press,on MondayBritain gave its approval for use of the vaccines in children 12 and older as part of a "tool kit" to avoid lockdowns this fall and ...

    Risk of Sudden Cardiac Death Rises in People With HIV

    People with HIV have an increased risk of sudden cardiac death, a new study warns, especially if the virus isn't well-controlled.

    Sudden cardiac death occurs when the heart unexpectedly stops beating, usually due to an abrupt electrical malfunction.

    "People living with HIV are already known to have a higher risk of heart attack, stroke, heart failure, blood clots in the lungs and pe...

    Monoclonal Antibody Treatments for COVID-19: An Expert Explains

    Monoclonal antibody infusions can help prevent severe COVID-19, but the best protection is to get vaccinated, experts say.

    Antibodies are made by the immune system to fight infections.

    "The problem is that our immune system takes two to three weeks to make good antibodies," said Dr. Turner Overton, co-director of the Alabama Vaccine Research Clinic at the University of Alabama at Bi...

    High Viral Load in Lungs Drives Fatal COVID-19: Study

    A high amount of coronavirus in the lungs is a major contributor to death in COVID-19 patients, new research shows.

    The findings challenge previous theories that simultaneous infections such as pneumonia or an overreaction of the body's immune system are significant factors in COVID-19 deaths, the researchers noted.

    To come to that conclusion, the investigators analyzed bacterial an...

    Your Young Child Is Sick: Is it COVID or RSV?

    A common bug called respiratory syncytial virus (RSV) circulating among American kids during what's normally its off-season may cause concern if parents don't know how to tell it apart from COVID-19, experts say.

    Getting RSV during the summer is unusual, but the U.S. Centers for Disease Control and Prevention recently issued an alert about a rise in RSV cases in Southern states.

    "We...

    Could a Long-Used Cholesterol Drug Fight Severe COVID-19?

    A drug that lowers cholesterol might help save hospitalized patients with COVID-19, a new, small Israeli study suggests.

    Researchers at Hebrew University of Jerusalem noted that COVID causes a big buildup of cholesterol, which results in inflammation in cells.

    In lab experiments, they found that the cholesterol-lowering drug fenofibrate (TriCor) effectively reduced damage to lung ce...

    When Is a Person With COVID-19 Most Infectious?

    New research delivers an answer to a burning question: When are COVID-19 patients most infectious?

    The answer? Two days before and three days after they develop symptoms.

    The findings highlight the importance of rapid testing and quarantine if someone is feeling sick, the study authors said.

    The researchers also found that infected people are more likely to be asymptomatic if ...

    Large-Scale Pandemics Aren't as Rare as You Think: Study

    Major pandemics aren't all that rare and they're likely to occur more often in the future, a new study claims.

    "The most important takeaway is that large pandemics like COVID-19 and the Spanish flu are relatively likely," study co-author William Pan said in a news release from Duke University, where he is an associate professor of global environmental health.

    That points to the nee...

    Study Gives Hope for 'Dream' Vaccine Against All COVID Variants

    A multi-purpose vaccine that would protect humans against any future COVID-19 variants could one day be possible, a new study suggests.

    The key to it all lies in a coronavirus scare that happened nearly two decades ago.

    People previously infected with SARS -- the original coronavirus pandemic from 2003 -- produced an incredibly powerful immune response when given the Pfizer COVID-19...

    Longer, Worse COVID Leaves Stronger Antibodies: Study

    Survivors of severe or long COVID-19 could have greater antibody protection against future infection than those whose illness was shorter or milder, new research suggests.

    For the study, a Rutgers University team followed 548 health care workers and 283 other workers from the start of the pandemic. Within six months, 93 (11%) of them tested positive for SARS-CoV-2 or for antibodies agains...

    No Lasting Lung Damage After Full Recovery From COVID-19

    If you suffered a bout of COVID-19 and your lungs took a beating, new research has reassuring news: You will likely be spared long-term respiratory damage.

    Scientists looked at COVID-19 survivors who had asymptomatic, moderate or severe COVID-19 infections and also underwent unrelated elective lung operations (for example, to treat lung nodules or lung cancer) at some point after they rec...

    Even Delta Variant Can't Evade Vaccine-Linked Antibodies: Study

    Antibodies generated by COVID-19 vaccines are effective against the Delta variant and other coronavirus variants of concern, new research shows.

    The findings may help explain why most vaccinated people have avoided the surge of Delta variant cases sweeping across the United States.

    "In face of...

    4 Out of 10 Parents Have No Plans to Get Child Vaccinated for School: Poll

    Almost 90% of U.S. parents plan to send their kids back to the classroom this fall, but fewer than 60% plan to get a COVID-19 vaccine for those who are old enough, a new poll reveals.

    Anxiety is also high among many parents, who wonder just how safe in-person learning will be as the highly contagious Delta variant spreads nationwide and the pandemic grinds on.

    "To feel safe sending ...

    Texas Governor Has Breakthrough COVID Infection

    Texas Governor Greg Abbott has tested positive for COVID-19 but has not experienced any symptoms, his office announced Tuesday.

    Abbott, who is fully vaccinated, is being treated with Regeneron's monoclonal antibodies in an effort to shorten the duration of the infection, his communications director Mark Miner said in a statement Tuesday afternoon, CBS News reported.

    "The go...

    Physics Shows Why 20 Seconds Is Right for Hand-Washing

    Twenty seconds.

    That's how long you need to wash your hands to remove germs, a new physics study confirms.

    Typical hand-washing guidelines -- including those from the U.S. Centers for Disease Control and Prevention -- advise scrubbing your hands for a minimum of 20 seconds.

    To assess that recommendation, researchers used a mathematical model to examine the key mechanics of h...

    Show All Health News Results